Skip to main content


Log in

Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma

  • Case Report
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript



Diagnosis of malignant ovarian tumours during pregnancy is uncommon. This report presents a case of a pregnant woman with ovarian dysgerminoma.

Case report

At 24 weeks gestation, a 33-year-old patient was diagnosed with unilateral ovarian dysgerminoma. Because the tumour was considered to be at an advanced stage (FIGO III), she received three cycles of paclitaxel and carboplatin. At 36 weeks gestation, she underwent a caesarean section, abdominal hysterectomy, bilateral salpingovarectomy, omentectomy, and lymphadenectomy. After surgery, she received three additional cycles of chemotherapy in an adjuvant setting. At birth, the infant was responsive to stimuli, and 20 months after delivery, the infant exhibited normal development.


This case report illustrates the difficulties arising from diagnosis of malignancy during pregnancy. Although combined treatment with paclitaxel and carboplatin is not considered a first-line therapy for ovarian dysgerminoma, in this case report it elicited an excellent response, and there were no adverse effects on the foetus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others


  1. Antonelli NM et al (1996) Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv 51(2):125–134

    Article  PubMed  CAS  Google Scholar 

  2. Smith LH et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189(4):1128–1135

    Article  PubMed  Google Scholar 

  3. Novak ER, Lambrou CD, Woodruff JD (1975) Ovarian tumors in pregnancy. An ovarian tumor registry review. Obstet Gynecol 46(4):401–406

    PubMed  CAS  Google Scholar 

  4. Doll DC, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16(5):337–346

    PubMed  CAS  Google Scholar 

  5. Zemlickis D et al (1992) Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152(3):573–576

    Article  PubMed  CAS  Google Scholar 

  6. Williams SF, Bitran JD (1985) Cancer and pregnancy. Clin Perinatol 12(3):609–623

    PubMed  CAS  Google Scholar 

  7. Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283–291

    Article  PubMed  CAS  Google Scholar 

  8. Oehler MK, Wain GV, Brand A (2003) Gynaecological malignancies in pregnancy: a review. Aust NZ J Obstet Gynaecol 43(6):414–420

    Article  Google Scholar 

  9. Partridge AH, Garber JE (2000) Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol 27(6):712–726

    PubMed  CAS  Google Scholar 

  10. Mizejewski GJ (2003) Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 58(12):804–826

    Article  PubMed  Google Scholar 

  11. Elit L et al (1999) An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 72(1):123–127

    Article  PubMed  CAS  Google Scholar 

  12. Han JY et al (2005) Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 19(4):557–561

    Article  PubMed  CAS  Google Scholar 

  13. Brewer M et al (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17(9):2670–2675

    PubMed  CAS  Google Scholar 

  14. De Giorgi U et al (2004) Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience. Am J Clin Oncol 27(5):457–460

    Article  PubMed  CAS  Google Scholar 

  15. Sood AK, Shahin MS, Sorosky JI (2001) Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 83(3):599–600

    Article  PubMed  CAS  Google Scholar 

  16. Mendez LE et al (2003) Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 102(5 Pt 2):1200–1202

    Article  PubMed  Google Scholar 

  17. Gemma R et al (1992) Lactate dehydrogenase (LDH)-linked immunoglobulin in a patient with Graves’ disease treated with methimazole. Intern Med 31(3):377–379

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Michael Hubalek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hubalek, M., Smekal-Schindelwig, C., Zeimet, A.G. et al. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet 276, 179–183 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: